Sr Group Director
Regeneron Pharmaceuticals, Inc.
Dr. Min Zhu, PhD, currently is a Sr Group Director at Regeneron Pharmaceuticals, Inc. She had more than 20 years of experience in Clinical Pharmacology and Clinical Drug Development and has worked in Pharmaceutical and Bio-Tech companies. Her focused research area is oncology and has worked on bispecific immune-oncology agents for more than 10 years. She was the Clinical Pharmacology Lead (Amgen) for registration of BLINCYTO, the first BiTE (bispecific T-cell engager) molecule for the treatment of relapsed and refractory acute lymphoblastic leukemia in adults and pediatric patients, and is the Clin Pharm lead for multiple bispecific programs for the treatment of hematology cancers and solid tumors at Regeneron.